BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37160725)

  • 1. The impact of the COVID-19 pandemic on antibiotic consumption and prevalence of pathogens in primary and secondary healthcare settings in Northern Ireland.
    Aldeyab MA; Crowe W; Karasneh RA; Patterson L; Sartaj M; Ewing J; Lattyak WJ; Al-Azzam S; Araydah M; Darwish Elhajji F; Kabbaha S; Conway BR; Conlon-Bingham G; Farren D; Scott M
    Br J Clin Pharmacol; 2023 Sep; 89(9):2851-2866. PubMed ID: 37160725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of national antibiotic stewardship and infection control strategies on hospital-associated and community-associated meticillin-resistant Staphylococcus aureus infections across a region of Scotland: a non-linear time-series study.
    Lawes T; Lopez-Lozano JM; Nebot CA; Macartney G; Subbarao-Sharma R; Dare CR; Wares KD; Gould IM
    Lancet Infect Dis; 2015 Dec; 15(12):1438-49. PubMed ID: 26411518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic consumption in hospitals during COVID-19 pandemic: a comparative study.
    Hussein RR; Rabie ASI; Bin Shaman M; Shaaban AH; Fahmy AM; Sofy MR; Lattyak EA; Abuelhana A; Naguib IA; Ashour AM; Aldeyab MA
    J Infect Dev Ctries; 2022 Nov; 16(11):1679-1686. PubMed ID: 36449638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic use in township hospitals during the COVID-19 pandemic in Shandong, China.
    Wang T; Shen L; Yin J; Zhou L; Sun Q
    Antimicrob Resist Infect Control; 2022 Dec; 11(1):164. PubMed ID: 36566210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The experience of an antimicrobial stewardship program and antibiotic consumption and resistance trends during the COVID-19 pandemic at a tertiary care center in Beirut.
    Haddad N; Zeenny RM; El Halabi C; Abdallah T; El Helou R; Zahreddine NK; Kanj SS; Rizk NA
    J Infect Public Health; 2024 Feb; 17(2):254-262. PubMed ID: 38128409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of coronavirus disease 2019 (COVID-19) on antimicrobial resistance among major pathogens causing healthcare-associated infection.
    Chang HC; Chang CH; Tien KL; Tai CH; Lin LM; Lee TF; Ku SC; Fang CT; Chen YC; Sheng WH
    J Formos Med Assoc; 2024 Jan; 123(1):123-132. PubMed ID: 37451958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial consumption in an acute NHS Trust during the COVID-19 pandemic: intervention time series analysis.
    Khan S; Bond SE; Lee-Milner J; Conway BR; Lattyak WJ; Aldeyab MA
    JAC Antimicrob Resist; 2024 Feb; 6(1):dlae013. PubMed ID: 38328263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.
    Lawes T; Lopez-Lozano JM; Nebot CA; Macartney G; Subbarao-Sharma R; Wares KD; Sinclair C; Gould IM
    Lancet Infect Dis; 2017 Feb; 17(2):194-206. PubMed ID: 27825595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the COVID-19 pandemic on hospital antimicrobial consumption in Croatia.
    Vlahović-Palčevski V; Rubinić I; Payerl Pal M
    J Antimicrob Chemother; 2022 Sep; 77(10):2713-2717. PubMed ID: 35869875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic consumption and antimicrobial resistance in the SARS-CoV-2 pandemic: A single-center experience.
    Sokolović D; Drakul D; Vujić-Aleksić V; Joksimović B; Marić S; Nežić L
    Front Pharmacol; 2023; 14():1067973. PubMed ID: 37007038
    [No Abstract]   [Full Text] [Related]  

  • 11. The interface between COVID-19 and bacterial healthcare-associated infections.
    O'Toole RF
    Clin Microbiol Infect; 2021 Dec; 27(12):1772-1776. PubMed ID: 34111586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Klebsiella pneumoniae bloodstream infection, antimicrobial resistance and consumption trends in Ireland: 2008 to 2013.
    Brady M; Cunney R; Murchan S; Oza A; Burns K
    Eur J Clin Microbiol Infect Dis; 2016 Nov; 35(11):1777-1785. PubMed ID: 27488438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point prevalence audit surveys of respiratory tract infection consultations and antibiotic prescribing in primary care before and during the COVID-19 pandemic in Ireland.
    Shah M; Fleming A; Barbosa TM; van der Velden AW; Parveen S; Vellinga A
    J Antimicrob Chemother; 2023 May; 78(5):1270-1277. PubMed ID: 36974983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 pandemic and the quality of antibiotic use in primary care: an interrupted time-series study.
    Domingues M; Torre C; Guerreiro JP; Barata P; Correia-Neves M; Rocha J; Sepodes B; Teixeira Rodrigues A
    Int J Qual Health Care; 2023 May; 35(2):. PubMed ID: 37226230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals.
    Rogues AM; Dumartin C; Amadéo B; Venier AG; Marty N; Parneix P; Gachie JP
    Infect Control Hosp Epidemiol; 2007 Dec; 28(12):1389-95. PubMed ID: 17994520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of COVID19 pandemic on the incidence of health-care associated Clostridioides difficile infection.
    Merchante N; Chico P; Márquez-Saavedra E; Riera G; Herrero R; González-de-la-Aleja P; Aller AI; Rodríguez JC; Rodríguez-Fernández M; Ramos JM; Trigo-Rodríguez M; Merino E
    Anaerobe; 2022 Jun; 75():102579. PubMed ID: 35500744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of an enhanced antibiotic stewardship on reducing methicillin-resistant Staphylococcus aureus in primary and secondary healthcare settings.
    Aldeyab MA; Scott MG; Kearney MP; Alahmadi YM; Magee FA; Conlon G; McElnay JC
    Epidemiol Infect; 2014 Mar; 142(3):494-500. PubMed ID: 23735079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of bacterial agents isolated from endotracheal aspirate cultures of Covid-19 general intensive care patients and their antibiotic resistance profiles compared to pre-pandemic conditions.
    Bahçe YG; Acer Ö; Özüdoğru O
    Microb Pathog; 2022 Mar; 164():105409. PubMed ID: 35041973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic Use in China's Public Healthcare Institutions During the COVID-19 Pandemic: An Analysis of Nationwide Procurement Data, 2018-2020.
    Yang Y; Geng X; Liu X; Wen X; Wu R; Cui D; Mao Z
    Front Pharmacol; 2022; 13():813213. PubMed ID: 35237164
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of Antibiotic Use Patterns and Trends Based on Procurement Data of Healthcare Institutions in Shaanxi Province, Western China, 2015-2018.
    Xu S; Yuan S; Kabba JA; Chen C; Liu W; Chang J; Fang Y
    Int J Environ Res Public Health; 2020 Oct; 17(20):. PubMed ID: 33081253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.